Home Oncology Long-lasting Radionuclide Therapy for Advanced Neuroendocrine Tumors Proves Effective

Long-lasting Radionuclide Therapy for Advanced Neuroendocrine Tumors Proves Effective

295
0

A first-in-human study presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates the benefits and safety of a new, long-lasting type of radionuclide therapy for patients with advanced, metastatic neuroendocrine tumors (NETs).

View article here

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.